Moneycontrol PRO
HomeNewsTrendsHealthToo early to say if COVID-19 booster shots will be needed: WHO Chief Scientist

Too early to say if COVID-19 booster shots will be needed: WHO Chief Scientist

WHO doesn't have the information necessary to make the recommendation on whether or not a booster will be needed, Swaminathan has said.

June 20, 2021 / 10:40 IST
World Health Organization (WHO) Chief Scientist Soumya Swaminathan (File image: Reuters).

World Health Organization (WHO) Chief Scientist Soumya Swaminathan (File image: Reuters).

World Health Organization's Chief Scientist Soumya Swaminathan believes that "science is still evolving" and it is too early to determine whether booster shots of COVID-19 will be needed to target emerging variants of the virus.

"We do not have the information that’s necessary to make the recommendation on whether or not a booster will be needed," Swaminathan told Bloomberg.

Track this LIVE blog for latest updates on coronavirus pandemic

At a time when high-risk people in most parts of the world weren't even partly vaccinated, making such a call would be "premature".

"Data from countries introducing precautionary extra inoculations later this year—particularly for vulnerable people whose immunity to SARS-CoV-2 may wane faster—will inform WHO’s guidance," she was quoted as saying.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Read | We’ll probably need booster shots for COVID-19. But when? And which ones?

On the mixing vaccines, Swaminathan said that early data from the UK, Spain and Germany suggested that using two different types of jabs generated more pain, fever and other minor side effects in comparison to two doses of the same vaccine.

"However, the so-called heterologous prime-boost combinations appear to spur a more robust immune response, leading to both higher levels of virus-blocking antibodies and the white blood cells that kill virus-infected cells," she added.

The discourse around booster shots has gathered steam as the highly transmissible variants such as Delta, first reported in India, continue to lead a surge in COVID-19 infections in multiple countries.

Studies are on to see whether a booster shot will increase antibodies and prolong protection against the virus.

Although many scientists estimate that the protection from vaccines will last at least a year, no one knows for sure. It is also unclear whether emerging variants of the coronavirus will change vaccination needs.

Click here for Moneycontrol's full coverage of COVID-19

Moneycontrol News
first published: Jun 20, 2021 10:40 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347